Use of hydroxyurea in French-speaking Sub-Saharan Africa
Annals of Hematology · 2025-02 · 104 (2) · 937-941
DOI: 10.1007/s00277-024-06180-2 ↗Kurz gefasst
Leitlinie in der Zeitschrift Annals of Hematology, online erschienen am 05.02.2025. Verfasst von Jean-Benoît Arlet und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Georges Pompidou European Hospital, AP-HP, French National Reference Center for Sickle Cell Anemia, Thalassemia, Oth…. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Antisickling Agents, Hydroxyurea. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The hydroxyurea is a save, affordable and essential medicine for sickle cell disease (SCD), reducing painful crises and mortality. To foster the prescription of hydroxyurea for patients with SCD in sub-Saharan African countries, the scientific advisory board of Drep.Afrique, a non-governmental organization dedicated to SCD in Africa, has developed a therapeutic guideline well suited to conditions on the ground. These guidelines answer three essential questions: which patients should be prioritized for treatment with hydroxyurea, which dose should be used, and what follow-up should be implemented in those low-resources countries? The guidelines are given as in a concise document for easy use by practitioners on the ground, available in English and in French.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Georges Pompidou European Hospital, AP-HP, French National Reference Center for Sickle Cell Anemia, Thalassemia, Other Rare Red Blood Cell Disorders and Erythropoiesis, Paris, and Univer…
- Pediatric Department Sickle Cell Referral Center, Intercommunal Hospital of Créteil, 94000, Creteil, France.
- Cheikh Anta Diop University, Dakar, Senegal.
- Albert Royer National Children Hospital, Dakar, Senegal.
- , Francfort-Sur-Le-Main, Germany.
- Department of Internal Medicine, Georges Pompidou European Hospital, AP-HP, French National Reference Center for Sickle Cell Anemia, Thalassemia, Other Rare Red Blood Cell Disorders and Erythropoiesis, Paris, France.
Zitieren
APA
Arlet, J. B., Bernaudin, F., Deme-Ly, I., Coulibaly, B., Corbasson, A., Diagne, I., Diallo, D., Diop, S., Eposse, C., Galacteros, F., Hermine, O., Kafando, E., Lainé, A., de Montalembert, M., Vodouhé, C., Vovor, A., Ranque, B., & Tshilolo, L. (2025). Use of hydroxyurea in French-speaking Sub-Saharan Africa. Annals of Hematology, 104(2), 937-941. https://doi.org/10.1007/s00277-024-06180-2
Vancouver
Arlet JB, Bernaudin F, Deme-Ly I, Coulibaly B, Corbasson A, Diagne I, et al. Use of hydroxyurea in French-speaking Sub-Saharan Africa. Annals of Hematology. 2025;104(2):937-941. doi:10.1007/s00277-024-06180-2
BibTeX
@article{Arlet2025,
author = {Arlet, Jean-Benoît and Bernaudin, Françoise and Deme-Ly, Indou and Coulibaly, Binta and Corbasson, Anne and Diagne, Ibrahima and Diallo, Dapa and Diop, Saliou and Eposse, Charlotte and Galacteros, Frédéric and Hermine, Olivier and Kafando, Eléonore and Lainé, Agnès and de Montalembert, Mariane and Vodouhé, Constant and Vovor, Ahoefa and Ranque, Brigitte and Tshilolo, Léon},
title = {Use of hydroxyurea in French-speaking Sub-Saharan Africa},
journal = {Annals of Hematology},
year = {2025},
volume = {104},
number = {2},
pages = {937--941},
doi = {10.1007/s00277-024-06180-2}
}
EUVIMED